Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

January 2017 - FRMC

Department
Patient Engagement Reduces Costs Among Crohn’s Patients
01/23/2017
A joint-venture patient engagement program helped to reduce relative risk and treatment costs among patients with Crohn’s disease.
A joint-venture patient engagement program helped to reduce relative risk and treatment costs among patients with Crohn’s disease.
A joint-venture patient...
01/23/2017
First Report Managed Care
Department
Improving Access to Urgent IBD Care
01/23/2017
A collaboration aimed at improving access to urgent care for patients with inflammatory bowel disease helped to reduce emergency department overutilization.
A collaboration aimed at improving access to urgent care for patients with inflammatory bowel disease helped to reduce emergency department overutilization.
A collaboration aimed at...
01/23/2017
First Report Managed Care
Department
ED Visits for Headaches Increasing Significantly Among Children
01/23/2017
Research presented at the AAP 2016 National Conference and Exhibition found a trend of pediatric patients reporting to the ED for headache-related reasons. 
Research presented at the AAP 2016 National Conference and Exhibition found a trend of pediatric patients reporting to the ED for headache-related reasons. 
Research presented at the AAP...
01/23/2017
First Report Managed Care
Department
Uninsured Children Transferred After ED Visits More Than Privately Insured Children
01/23/2017
Transfers from the emergency department to another facility occur more frequently among pediatric patients without insurance or with Medicaid.
Transfers from the emergency department to another facility occur more frequently among pediatric patients without insurance or with Medicaid.
Transfers from the emergency...
01/23/2017
First Report Managed Care
Department
Arzerra “Highly Cost-Effective” Among Patients With Relapsed Chronic Lymphocytic Leukemia
01/23/2017
Researchers found that Arzerra (ofatumumab; Novartis) in combination with fludarabine and cyclophosphamide was more cost-effective than fludarabine and cyclophosphamide alone.
Researchers found that Arzerra (ofatumumab; Novartis) in combination with fludarabine and cyclophosphamide was more cost-effective than fludarabine and cyclophosphamide alone.
Researchers found that Arzerra...
01/23/2017
First Report Managed Care
Department
Costs Similar Among Multiple Myeloma Patients Treated With Kyprolis vs Pomalyst
01/23/2017
According to recent research presented at the 2016 ASH Annual Meeting and Exposition, multiple myeloma treatment costs are not significantly different when using Kyprolis (carfilzomib; Amgen) compared to treatment with Pomalyst (pomalidomide;...
According to recent research presented at the 2016 ASH Annual Meeting and Exposition, multiple myeloma treatment costs are not significantly different when using Kyprolis (carfilzomib; Amgen) compared to treatment with Pomalyst (pomalidomide;...
According to recent research...
01/23/2017
First Report Managed Care
Department
Novel Device Provides Rapid, Low-Cost Blood Clot Testing
01/23/2017
According to recent research presented at the 2016 ASH Annual Meeting and Exposition, a newly developed handheld device can offer rapid and comprehensive assessment of blood clotting using less than a drop of blood.
According to recent research presented at the 2016 ASH Annual Meeting and Exposition, a newly developed handheld device can offer rapid and comprehensive assessment of blood clotting using less than a drop of blood.
According to recent research...
01/23/2017
First Report Managed Care
Department
Bioengineering Innovations Highlight the Future of Cancer, Hemophilia Treatment
01/23/2017
A collection of studies presented at the 2016 ASH Annual Meeting and Exposition highlighted advances in biomedical engineering that could improve the delivery of treatments for patients with cancer and hematological-related illnesses. 
A collection of studies presented at the 2016 ASH Annual Meeting and Exposition highlighted advances in biomedical engineering that could improve the delivery of treatments for patients with cancer and hematological-related illnesses. 
A collection of studies...
01/23/2017
First Report Managed Care
Department
ASCO, ESMO Value Frameworks Imperfectly Apply to Hematology
01/23/2017
Current value frameworks issued by leading medical societies may not be easily generalizable to the treatment of hematologic malignancies.
Current value frameworks issued by leading medical societies may not be easily generalizable to the treatment of hematologic malignancies.
Current value frameworks issued...
01/23/2017
First Report Managed Care
Department
Cessation of Treatment May Be Possible for Patients With Chronic Myeloid Leukemia
01/23/2017
Patients with stable chronic myeloid leukemia can safely cease or reduce treatment with tyrosine kinase inhibitors to avoid side effects and treatment costs. 
Patients with stable chronic myeloid leukemia can safely cease or reduce treatment with tyrosine kinase inhibitors to avoid side effects and treatment costs. 
Patients with stable chronic...
01/23/2017
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Cigna Reports Cost Savings Associated With Fusing Medical, Drug, and Behavioral Benefits
01/07/2020
"Our integrated approach maximizes every opportunity to deliver a health care experience that is affordable, predictable and simple," said Matt Totterdale, senior vice president, Cigna Pharmacy.
"Our integrated approach maximizes every opportunity to deliver a health care experience that is affordable, predictable and simple," said Matt Totterdale, senior vice president, Cigna Pharmacy.
"Our integrated approach...
01/07/2020
First Report Managed Care
News
Foes of new health system more likely to vote Nov. 2
09/27/2010
09/27/2010
First Report Managed Care
Conference Insider
New Shingles Vaccine Cost-Effective, Cost-Saving Compared With Zostavax
05/31/2018
Research presented at the AMCP 2018 Annual Meeting found that Shingrix (non-live adjuvanted subunit vaccine; GlaxosmithKline) is cost-effective when compared with no vaccination and cost-saving compared with an older shingles vaccine.
Research presented at the AMCP 2018 Annual Meeting found that Shingrix (non-live adjuvanted subunit vaccine; GlaxosmithKline) is cost-effective when compared with no vaccination and cost-saving compared with an older shingles vaccine.
Research presented at the AMCP...
05/31/2018
First Report Managed Care
News
Jentadueto Approved for Type 2 Diabetes
01/31/2012
The US Food and Drug Administration (FDA) announced on Monday that it had approved Jentadueto (linagliptin/metformin hydrochloride), an oral combination therapy to treat patients with type 2 diabetes. The drug is co-marketed by Boehringer...
The US Food and Drug Administration (FDA) announced on Monday that it had approved Jentadueto (linagliptin/metformin hydrochloride), an oral combination therapy to treat patients with type 2 diabetes. The drug is co-marketed by Boehringer...
The US Food and Drug...
01/31/2012
First Report Managed Care
News
Value-Based Contracting Showing Greater Value for Care Provided, Innovative Opportunities
07/13/2015
San Diego—Value-based contracting is demonstrating greater value for care provided, while innovative contracting opportunities are expected to increase in the future, according to a session at the AMCP meeting that included both payer and...
San Diego—Value-based contracting is demonstrating greater value for care provided, while innovative contracting opportunities are expected to increase in the future, according to a session at the AMCP meeting that included both payer and...
San Diego—Value-based...
07/13/2015
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

January 2017 Volume 14 Issue 1

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement